Search research articles
Contact Us
Filters
Showing results (181-190 of 590) with videos related to
Page
of 59
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2011
Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin
Ellie J C Goldstein, Joseph S Solomkin, Diane M Citron, et al.
Anaerobe
|
November 5, 2013
Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?
Ellie J C Goldstein, Diane M Citron, Marina C Claros, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1997
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates
E J Goldstein, D M Citron, S Hunt Gerardo, et al.
Lancet (London, England)
|
July 27, 1974
Effect of meals on rifampicin absorption
D I Siegler, M Bryant, D M Burley, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans
E J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy
|
May 21, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans
E J Goldstein, D M Citron, S Hunt Gerardo, et al.
The Journal of Antimicrobial Chemotherapy
|
May 13, 1998
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens
E J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2000
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections
E J Goldstein, D M Citron, C Vreni Merriam, et al.
The Journal of Infectious Diseases
|
November 1, 1979
Bacteriology of rattlesnake venom and implications for therapy
E J Goldstein, D M Citron, H Gonzalez, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum
Gary E Stein, Sharon Schooley, Kerin L Tyrrell, et al.
Page
of 59
Search research articles
Search
Showing results (181-190 of 590) with videos related to
Sort By:
Page
of 59
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2011
Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin
Ellie J C Goldstein, Joseph S Solomkin, Diane M Citron, et al.
Anaerobe
|
November 5, 2013
Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?
Ellie J C Goldstein, Diane M Citron, Marina C Claros, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1997
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates
E J Goldstein, D M Citron, S Hunt Gerardo, et al.
Lancet (London, England)
|
July 27, 1974
Effect of meals on rifampicin absorption
D I Siegler, M Bryant, D M Burley, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans
E J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy
|
May 21, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans
E J Goldstein, D M Citron, S Hunt Gerardo, et al.
The Journal of Antimicrobial Chemotherapy
|
May 13, 1998
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens
E J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy
|
August 22, 2000
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections
E J Goldstein, D M Citron, C Vreni Merriam, et al.
The Journal of Infectious Diseases
|
November 1, 1979
Bacteriology of rattlesnake venom and implications for therapy
E J Goldstein, D M Citron, H Gonzalez, et al.
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum
Gary E Stein, Sharon Schooley, Kerin L Tyrrell, et al.
Page
of 59